or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    CARM F Carisma Therapeutics, Inc. 2.92
    BCEL F Atreca, Inc. 2.11
    RLAY F Relay Therapeutics, Inc. 2.00
    CASI D CASI Pharmaceuticals, Inc. 1.69
    ACLX D Arcellx, Inc. 1.57
    ORIC F Oric Pharmaceuticals, Inc. 1.55
    MRKR F Marker Therapeutics, Inc. 1.22
    LGND C Ligand Pharmaceuticals Incorporated 1.22
    NXTC D NextCure, Inc. 1.21
    GMAB D Genmab A/S 1.11
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Medicine Cancer Biotechnology Biopharmaceutical Cancer Treatment Clinical Medicine Multiple Myeloma Treatment Of Cancer Immune System Immunology Immunotherapies Immunotherapy Ovarian Cancer Tumor Acute Myeloid Leukemia Advanced Solid Tumors Antibodies Antibody Drug Conjugate Cancer Immunotherapy Cell Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    PJP A PowerShares Dynamic Pharmaceuticals 4.16
    IDNA B iShares Genomics Immunology and Healthcare ETF 4.05
    FBT C First Trust Amex Biotech Index Fund 3.25
    CNCR D Loncar Cancer Immunotherapy ETF 3.24
    BBP C BioShares Biotechnology Products Fund 2.5
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare IDNA to BBP Compare PJP to CNCR Compare PJP to FBT

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 17 LGND Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 LGND Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
        May 17 LGND Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
        May 17 LGND Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 LGND Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
        May 16 LGND Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
        May 16 CARM Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
        May 16 LGND Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
        May 15 MRKR Marker Therapeutics GAAP EPS of -$0.27 misses by $0.02, revenue of $1.24M
        May 15 MRKR Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 15 LGND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 15 GMAB Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'
        May 14 LGND Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
        May 14 GMAB Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
        May 14 LGND Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
        May 14 LGND Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
        May 14 LGND Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
        May 14 CARM Is There An Opportunity With Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 46% Undervaluation?
        May 14 GMAB Danish biotech says companies should tap into China’s ‘impressive innovation’
        May 13 LGND Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Cancer Biotechnology Biopharmaceutical Cancer Treatment Clinical Medicine Multiple Myeloma Treatment Of Cancer Immune System Immunology Immunotherapies Immunotherapy Ovarian Cancer Tumor Acute Myeloid Leukemia Advanced Solid Tumors Antibodies Antibody Drug Conjugate Cancer Immunotherapy Cell Therapy
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags